Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast 24-week trial on lung hyperinflation in COPD
2004-000288-89Phase 3Completed
- Sponsor
- Altana Pharma
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Roflumilast with Placebo (2 arms). Primary endpoint: Mean change in post-bronchodilator FRCpl. Started Sep 2004; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2004-000288-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000288-89.